意大利卡拉布里亚地区10年儿科药物不良反应报告分析
该研究基于意大利药物警戒数据库,提取2010至2019年卡拉布里亚地区18岁以下人群的个体病例安全报告,排除重复和疫苗报告后分析395份儿科报告对应的556例不良反应。
要点
- 2010至2015年报告数增加,2015年后报告率下降。
- 抗感染药物和皮肤疾病分别为最常见药物类别和不良反应类型。
核心结论
- 该研究概述了卡拉布里亚地区儿科人群报告的药物不良反应,强调需针对特定年龄亚组和特定药物加强监测。
研究设计与样本
- 回顾性分析意大利药物警戒数据库中2010至2019年卡拉布里亚地区18岁以下个体的ICSRs,排除重复和疫苗报告后纳入395份儿科ICSRs,对应556例不良反应。
主要发现
- 2010至2015年ICSRs数量增加,2015年后报告率下降。
- ICSRs中约52%涉及男孩,除新生儿外所有年龄组均呈此趋势。
- 报告者主要为医生(64.1%),其他医疗专业人员占22.5%,药师占9.9%。
- 抗感染药物(全身用)和皮肤疾病分别为最常报告的药物组和不良反应类别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The paucity of pediatric clinical trials has led to many medicines frequently prescribed to children without a license for use in pediatrics, resulting in an increased risk of adverse drug reactions. Pharmacovigilance databases remain, among others, a valuable tool for evaluating pediatric drug safety in the real-life setting. OBJECTIVE: We aimed to characterize pediatric adverse drug reactions reported in the Italian Pharmacovigilance database coming from the Calabria region (Southern Italy) over 10 years. METHODS: All Individual Case Safety Reports (ICSRs) concerning individuals aged under 18 years were extracted from 2010 to 2019. Duplicate and vaccine ICSRs were excluded. The remaining ICSRs were analyzed with respect to patients' demographic data, suspected drugs, and category of adverse drug reactions across different age groups. RESULTS: Among 6529 selected ICSRs, 395 pediatric ICSRs corresponding to 556 adverse drug reactions were analyzed. From 2010 to 2015, an increasing number of ICSRs were observed, but the reporting rate decreased after 2015. The highest proportion of ICSRs concerned children and adolescents. Around 52% of ICSRs involved boys: a trend observed in all age groups excluding newborns. Sixty ICSRs were serious and among them, 75% required hospitalization mainly in children and adolescents. Most of the ICSRs were issued by physicians (64.1%), followed by other healthcare professionals (22.5%) and pharmacists (9.9%). Anti-infective agents for systemic use and skin disorders were, respectively, the most frequently reported drug group and adverse drug reaction category. CONCLUSIONS: This study provides an overview of adverse drug reactions reported in the pediatric population of the Calabria region and emphasizes the need for strengthening the surveillance in specific age subgroups and on given drugs in relation to their pattern of use.
引用
- Leporini C, De Sarro C, Palleria C, et al. Pediatric Drug Safety Surveillance: A 10-Year Analysis of Adverse Drug Reaction Reporting Data in Calabria, Southern Italy. Drug Saf. 2022. PMID: 36112324. doi:10.1007/s40264-022-01232-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。